-

Enhanced Bayer Carbon Program Offers Growers New Opportunities in 2021 and Beyond

Elements include expansion into new geographies and increased grower eligibility, enabling more growers to participate and benefit

ST. LOUIS--(BUSINESS WIRE)--Building on the success of the Bayer Carbon Program launched last summer, the company announced today enhancements to the program, providing new opportunities for U.S. growers to participate for the 2021-22 program season.

Highlights include a significant geographic expansion, nearly doubling the number of states where growers are eligible to participate. For the first time, growers who have previously adopted some climate-smart farming practices also may be able to enroll those acres in the program.

The Bayer Carbon Program takes a farmer-centric approach by offering growers simplicity, certainty and flexibility. By paying U.S. farmers for implementing climate-smart farming methods such as strip- or no-till and cover crops, which help sequester carbon in the soil, farmers receive guaranteed payments and are rewarded for how they produce, not just what they produce.

“Farmers are at the center of the solution when it comes to helping sequester carbon and addressing climate change,” said Jackie Applegate, President of Crop Science, North America. “By enabling farmers to benefit in a simple and transparent way, Bayer is uniquely positioned to help growers capture value created by these sustainable farming practices.”

The streamlined approach has become a hallmark of Bayer’s program. It offers certainty and pays growers for the verified practices farmers adopt on each enrolled acre, without growers having to decipher the amount of carbon they generate.

“Through our Carbon Advisory Panel and meetings with growers, we’ve heard from farmers that they appreciate the simplicity of the program, which allows them to focus on what they do best – raise a crop,” said Leo Bastos, Head of Carbon Business Model. “We are excited to build on the success of the program’s first year and offer even more growers the chance to participate in the program. This is just the beginning. We’re continually exploring new ways and opportunities to help deliver added benefits to farmers.”

In addition to generating additional revenue, participating in initiatives like the Bayer Carbon Program and implementing climate-smart farming practices may provide farmers with important benefits such as the potential for improved soil health that can result in increased yields and profitability of farmers’ operations.

Enhancements for the 2021-2022 program season include eligibility for growers who have adopted strip- or no-till or cover crops on fields on or after January 1, 2012.

In addition to the nine states that were part of the program’s first year, new states where growers are now eligible to participate include: Wisconsin, South Dakota, Nebraska, Arkansas, Mississippi, Louisiana, Maryland and Delaware.

For a complete list of eligible geographies, to learn more or enroll in the 2021 Bayer Carbon Program, please visit www.BayerCarbon.com.

About Bayer

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to help people and planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to drive sustainable development and generate a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2020, the Group employed around 100,000 people and had sales of 41.4 billion euros. R&D expenses before special items amounted to 4.9 billion euros. For more information, go to www.bayer.com.

Contacts

Bayer - Brian Leake 314.370.3285
Brian.Leake@Bayer.com

Bayer


Release Versions

Contacts

Bayer - Brian Leake 314.370.3285
Brian.Leake@Bayer.com

More News From Bayer

Bayer Starts Phase IIa Study for Treatment of Patients With Alport Syndrome

BERLIN--(BUSINESS WIRE)--Bayer announced today initiation of a Phase IIa clinical trial with BAY 3401016, an investigational monoclonal antibody with potential to block a protein called Semaphorin 3A (Sema3A), which is thought to be involved in the progression of kidney damage in Alport Syndrome (AS), a rare genetic disorder. The first-in-patient study, ASSESS, is a randomized, double-blind, placebo-controlled, group-comparison trial (NCT07211685), with an extension phase, which will investigat...

RSNA25: Pediatric Study for Bayer's Investigational MRI Contrast Agent Gadoquatrane Meets Primary and Secondary Endpoints

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer, a global leader in radiology, today revealed results from the QUANTI Pediatric study, adding to the pharmacokinetic, safety and efficacy data of the investigational low-dose MRI gadolinium-based contrast agent (GBCA) gadoquatrane. QUANTI Pediatric evaluated gadoquatrane in children with known or suspected disease undergoing contrast-enhanced magnetic resonance imaging (MRI) at a gadolinium dose of 0.04 mmol Gd/kg body weight, representing a dose reduction...

Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer announced today the start of its Phase III study SUNFLOWER, an investigational study evaluating the efficacy and safety of 52mg levonorgestrel-releasing intrauterine system Mirena® for the treatment of nonatypical endometrial hyperplasia (NAEH) in women. NAEH is an abnormal thickening of the lining of the uterus, known as the endometrium, due to an imbalance between estrogen and progesterone levels. This condition is classified as nonatypical as the cells...
Back to Newsroom